BR-55

N/A

Report date: 2025/02/11 10:46:20

Base Information

Drug NameBR-55
Drug Alias NameBR-55BR55 CEUS
ClassificationDiagnostic agent (In vivo) > Contrast agent
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonists
TargetsVascular endothelial growth factor receptor 2
Therapy Area/IndicationsContrast agentsDiagnostic agentsInflammation +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSonus Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBracco Suisse SaBracco International BvBracco Imaging Medical Technologies (Shanghai) Co Ltd
Inactive CompaniesBracco Diagnostics Inc
Active IndicationsContrast agentsDiagnostic agentsInflammation +[4] 
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A